share_log
Reuters ·  May 8 16:44
Anika Therapeutics Inc Sees Adjusted Ebitda for 2024 to Be $25 to $30 Million
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment